Prof. Dr. med. Elke Jäger (Chefärztin)
Services search (in the department)
Illness | Number of cases |
---|---|
Malignant neoplasm of bronchus and lung (C34.1) | 239 |
Malignant neoplasm of stomach - Malignant neoplasm of cardia (C16.0) | 216 |
Non-follicular lymphoma (C83.3) | 162 |
Malignant neoplasm of pancreas - Malignant neoplasm of head of pancreas (C25.0) | 161 |
Malignant neoplasm of rectum (C20) | 145 |
Malignant neoplasm of bronchus and lung (C34.3) | 142 |
Malignant neoplasm of breast (C50.9) | 112 |
Malignant neoplasm of bronchus and lung (C34.0) | 106 |
Malignant neoplasm of pancreas - Malignant neoplasm of tail of pancreas (C25.2) | 95 |
Malignant neoplasm of bronchus and lung (C34.9) | 81 |
Treatment | Number |
---|---|
(9-984.7) | 551 |
(9-984.b) | 545 |
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.22) | 510 |
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.33) | 458 |
(9-984.8) | 353 |
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0) | 339 |
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0) | 275 |
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11) | 250 |
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.12) | 232 |
(8-98e.1) | 190 |
Bezeichnung | |
Teilnahme externe Qualitätssicherung | 0 |
Bezeichnung | |
Teilnahme externe Qualitätssicherung | 0 |
Bezeichnung | |
Teilnahme externe Qualitätssicherung | 1 |
Bezeichnung | |
Teilnahme externe Qualitätssicherung | 0 |
No. | Explanation |
---|---|
CQ01 |
Number | Group |
---|---|
191 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
37 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
20 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
Job | Explanation |
---|---|
Lectureships / teaching posts at colleges and universities | |
Initiation and management of uni-centric/multi-centric clinical/scientific studies | |
Project-related cooperation with colleges and universities | |
Student training (clinical traineeship / internship year) | |
Participation in multi-centre Phase I/II studies | |
Participation in multi-centre phase III/IV studies | |
Editors of scientific journals/textbooks |
No. | Training in other healing professions | Comment |
---|---|---|
HB07 | Surgical technical assistant (m/f) | |
HB15 | Anaesthesia technical assistant (m/f) | |
HB19 | Nursing professionals | |
HB01 | Nurse and health care worker (m/f) | |
HB20 | Nursing professional B. Sc. |
Herr Frank Welsch-Lehmann
Patientenfürsprecher
Steinbacher Hohl 2-26
60488 Frankfurt am Main
Phone: 0151-40900189-
Mail: ED.GHHTS@knarF.nnamheL-hcsleW
Julia Stahn
Lob & Kritik
Steinbacher Hohl 2-26
60488 Frankfurt am Main
Phone: 069-7601-4777
Mail: ed.ghhts@negnudlemkceur
Frau Nathalie Kalisz
Leitung Qualitäts- und Klinisches Risikomanagement
Steinbacher Hohl 2-26
60488 Frankfurt am Main
Phone: 069-7601-1
Mail: ed.wnhk@eilahtan.zsilak
Prof. Dr. med. Siegbert Rossol
Ärztlicher Direktor
Steinbacher Hohl 2-26
60488 Frankfurt am Main
Phone: 069-7601-3370
Mail: ed.wnhk@tevassile.uolevanab
Jürgen Maurer
Leiter der Zentralapotheke
Steinbacher Hohl 2-26
60488 Frankfurt am Main
Phone: 069-7601-1
Mail: ed.wnhk@negreuj.reruam